Scotiabank Analysts Predict 87.66% Upside for BridgeBio Pharma, Recommending Sector Outperform
🌥️Trending News BRIDGEBIO ($NASDAQ:BBIO): BridgeBio Pharma is a biopharmaceutical company that focuses on developing life-changing therapies for patients with genetic [...]
Bridgebio Pharma Intrinsic Value – Wells Fargo Gives BridgeBio Pharma Inc an “Overweight” Rating
🌧️Trending News BRIDGEBIO ($NASDAQ:BBIO): BridgeBio Pharma Inc, a biopharmaceutical company focused on developing life-altering genetic medicines, has recently been given [...]
Swiss National Bank Invests $3.30 Million in BridgeBio Pharma, Inc
🌥️Trending News BRIDGEBIO ($NASDAQ:BBIO): The Swiss National Bank has recently announced their investment of $3.30 million into BridgeBio Pharma, Inc. [...]
BridgeBio Pharma to Present ATTR-CM Study Data at AHA 2023 Scientific Sessions
🌥️Trending News BRIDGEBIO ($NASDAQ:BBIO): BridgeBio Pharma is a biopharmaceutical company that develops treatments for genetic diseases and cancer. They are [...]
Allspring Global Investments Holdings LLC Reduces Stake in BridgeBio Pharma, by 2699 Shares
☀️Trending News BridgeBio Pharma, Inc. has recently seen a significant decrease in its stock as Allspring Global Investments Holdings LLC [...]
BRIDGEBIO PHARMA Reports 97.8% Decrease in Revenue for Q2 2023
🌥️Earnings Overview For the second quarter of fiscal year 2023, BRIDGEBIO PHARMA ($NASDAQ:BBIO) reported total revenue of USD 1.6 million, [...]
Bridgebio Pharma Intrinsic Value – BridgeBio Pharma Reports Total Revenue of USD 1.6 Million, Net Income of USD -157.9 Million in Q2 2023
🌥️Earnings Overview BRIDGEBIO ($NASDAQ:BBIO): For the second quarter of 2023, BridgeBio Pharma reported total revenue of USD 1.6 million and [...]
BridgeBio Pharma’s Stock Price Expected to Reach $40.00 in One Year Despite Wednesday’s Dip
🌥️Trending News BridgeBio Pharma Inc. has been making headlines recently as its stock price closed at $16.81 on Wednesday, July [...]
BridgeBio Pharma Stock Drops Ahead of Drug Data Release
🌥️Trending News BRIDGEBIO ($NASDAQ:BBIO): BridgeBio Pharma has seen its stock drop in recent trading after JP Morgan offered commentary on [...]
Bridgebio Pharma Stock Intrinsic Value – BridgeBio Pharma, Sees Significant Reduction in Short Interest at Defense World
☀️Trending News BRIDGEBIO ($NASDAQ:BBIO): BridgeBio Pharma, Inc. has seen a significant reduction in short interest at Defense World. This decline [...]
